This bill requires Michigan health insurers to cover group prenatal care services for all policyholders. It defines these services as evidence-based, group-based prenatal visits in a family-centered setting that include health assessments, social support, education, and peer interaction. The law applies to all health insurance policies issued in Michigan, directly affecting pregnant individuals and their insurers by mandating coverage for this specific care model.
SB 399 amends Michigan's definition of "drug paraphernalia" in the Public Health Code to explicitly exclude certain testing products, like fentanyl test strips, from being classified as paraphernalia. The bill states that tools used to detect harmful chemicals in controlled substances - such as strips for testing fentanyl - do not count as drug paraphernalia under state law. This change directly affects individuals using these testing products for safety, including people who use or distribute them to prevent overdoses. The amendment aims to remove legal barriers for harm-reduction tools without altering other provisions about paraphernalia.
SB 397 removes the prior authorization requirement for specific prescription drugs under Michigan's medical assistance program (Medicaid). This directly affects Medicaid beneficiaries and healthcare providers by allowing immediate coverage for designated drugs without waiting for insurer approval. The bill amends state law to automatically cover these medications, eliminating a step that previously delayed access. It applies only to drugs explicitly named in the legislation, streamlining treatment for covered conditions.
SB 400 prohibits Michigan health insurers from requiring prior authorization for medications treating opioid use disorder or alcohol use disorder. This directly affects health insurance companies and patients seeking these specific treatments, removing a common administrative barrier. The bill amends Michigan’s Insurance Code to explicitly ban prior authorization requirements for these medications, using the existing definition of "prior authorization" from Section 2212e. The law ensures faster access to evidence-based treatment without insurer delays.
SB 401 requires doctors to co-prescribe naloxone - a medication that reverses opioid overdoses - whenever they prescribe opioid painkillers. This directly affects healthcare providers who prescribe opioids and their patients, mandating that naloxone be provided at the same time as the opioid prescription. The bill amends existing law to make this co-prescribing a standard requirement, not an option. It aims to reduce opioid overdose deaths by ensuring patients have immediate access to naloxone when prescribed opioids. The bill passed the legislature with strong support on July 1, 2025.
SB 404 requires public schools in Michigan to ensure at least one staff member at each school is trained to administer naloxone (an opioid overdose reversal medication) if the state health department provides it at no cost. Schools must develop policies requiring staff to notify parents when naloxone is used and call 9-1-1 for suspected opioid overdoses. The bill directly affects public school districts, intermediate districts, and public school academies by mandating training and response protocols for opioid-related emergencies. It specifies naloxone must be FDA-approved and defines "opioid-related overdose" to include symptoms like respiratory depression or unconsciousness needing medical help.
SB 403 requires Michigan pharmacists to dispense certain medications used to treat addiction without unnecessary delay. This directly affects pharmacists who handle these medications and patients seeking treatment for substance use disorders. The bill amends Michigan's Pharmacy Act (MCL 333.1101 et seq.) by adding a new provision that eliminates administrative barriers causing delays in providing these critical medications. It establishes a clear requirement for prompt dispensing while maintaining pharmacists' existing professional responsibilities.
SB 156 expands the authority of Michigan's Office of the Legislative Corrections Ombudsman to investigate complaints about the Department of Corrections. The bill requires the ombudsman to create a standardized complaint form (available online and in correctional facilities) and grants access to department records - including prisoner medical, mental health, and mortality records - without needing a release. It also allows the ombudsman to enter correctional facilities for inspections at any time (including emergencies like riots), consult with qualified experts after background checks, and hold informal hearings. This directly affects prisoners, their family members, prisoner advocates, and the Department of Corrections by strengthening oversight of correctional operations.
SB 219 revises Michigan's mental health hospitalization procedures by updating the definition of a "person requiring treatment" under the Mental Health Code. It clarifies that individuals with dementia, epilepsy, or substance use disorders alone do not qualify for involuntary hospitalization unless they meet specific criteria related to risk of harm, inability to meet basic needs, or refusal of necessary treatment with documented risk. The bill modifies police protocols for protective custody (requiring family contact options and documentation), mandates a psychiatrist's examination within 24 hours of hospitalization, and updates referral processes between screening units and hospitals. These changes directly affect individuals with mental illness who meet the revised criteria and the healthcare providers and law enforcement involved in their care.
SB 222 expands who can petition for continued involuntary mental health treatment under Michigan's assisted outpatient program. It adds psychiatric nurse practitioners and physician assistants (working under a psychiatrist's delegation) to the list of eligible petitioners and allows individuals aged 18 or older to file petitions for themselves. Petitions must include a clinical certificate and evidence of a psychiatrist's consultation (unless the filer is a psychiatrist), along with details about the treatment program and estimated duration needed. This change directly affects patients requiring ongoing treatment and increases the number of authorized mental health providers who can initiate the petition process.
